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1. Introduction 
Patients with an implantable cardioverter defibrillator (ICD) are not routinely referred to 
Cardiac Rehabilitation (CR) due to fears that exercise may induce ventricular 
tachyarrhythmias. Meta analyses and systematic reviews have shown that a CR program 
with an exercise component can improve survival, as well as non-fatal disease 
manifestations, functional capacity and quality of life (QOL) in patients with previous 
myocardial infarction or cardiac surgery (Ades 2001; Lewin et al., 2001; Wenger 2008). 
Whether the same is true for patients with an ICD is not clear, especially as these patients 
may have ischaemic or non-ischaemic causes for their propensity for ventricular 
tachyarrhythmias, and are more likely to need treatment for heart failure. There is evidence 
that exercise programs can improve functional status and counter deconditioning in cardiac 
patients with heart failure ( Smart and Marwick 2004 ). 
Most previous studies which have examined the safety of exercising ICD patients have been 
small, with less than 100 patients in their studies ( Belardinelli et al., 2006; Chinnaiyan et al., 
2007; Dougherty et al., 2008; Fan et al., 2009; Fitchet et al., 2003; Vanhees et al., 2004 ) . A 
notable exception was the HF-ACTION cohort, in which 1285 patients had an ICD 
implanted before or during the trial and had at least one exercise test performed after ICD 
implantation ( Keteylan et al., 2009 ). This large study clearly demonstrated the safety of 
exercise testing in ICD patients, but did not show the changes in workloads achievable 
during the course of a CR program, or examine QOL issues. 
Exercise capacity at treadmill testing, expressed as peak metabolic equivalents ( METS ), has 
been shown to be of prognostic significance ( Kokkinos et al., 2007 ), with each 1 MET 
increase in exercise capacity being associated with a 13% decrease in mortality (mean 
follow-up 7.5 years). This data suggests that exercise programs should aim to improve 
functional capacity in cardiac patients, and endeavour to help sustain this level of functional 
improvement over time. 
2. Study aims 
The current study was designed to document the safety and benefits of CR, which included 
exercise training and testing, in patients with an ICD. In addition to documenting morbidity 
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and mortality associated with the CR program, the study examined the increase in 
functional capacity achievable over the course of the CR program, as well as the potential 
improvements possible in QOL measures during the program. 
3. Methodology 
Consecutive patients with an ICD who entered a single comprehensive tertiary CR program 
in Sydney, Australia, from 1997 to 2010 were included. Prospective data was analyzed 
including demographics, past medical history, cardiac risk factors, medications, exercise 
days, dropout status, left ventricular ejection fraction by gated heart pool scan (LVEF,%), 
functional capacity, QOL and outcome indicators, program morbidity, and 1 year mortality 
post CR. 
Exercise capacity was assessed in all patients by functional testing at the beginning of the 
CR program, and an exercise program, including both aerobic and resistive exercise 
regimes, was prescribed. All ICD patients were exercised with a wireless monitor linked to a 
central computer. Exercise capacity after the 6 week CR program was also assessed in 
patients completing the program.  
All patients had education, assessment and counselling sessions as well as exercise training 
as previously described ( Briffa et al., 2009; Zecchin et al., 1999 ). Secondary prevention 
strategies were also emphasized. All patients, including CR drop-outs, were followed-up by 
telephone contact for 1 year post CR. 
Quality of Life (QOL) was objectively measured using two self-report questionnaires, the 
SF-36 ( v1 ) and the DASS21, and was assessed before and after the program.  
The SF-36 (v1) Health Survey is a widely used generic questionnaire with standardized 
scores used to measure physical and social functioning, physical and emotional roles, bodily 
pain, vitality, mental health and general health perceptions (Ware and Sherbourne 1992). 
For this questionnaire, a higher score indicates a better level of physical and social 
functioning, vitality, mental health status and general health. Conversely, a higher score 
indicates a lower level of bodily pain. Cronbach’s scales of the SF-36 (v1) exceed alpha 0.8, 
except for social functioning (a = 0.76). The questionnaire can be compared to previously 
published data describing QOL in the normal Australian population – Australian Bureau of 
Statistics ( ABS ), 1995.  
The DASS21 is a 21 item self-report inventory that yields 3 factors: depression (DEP), anxiety 
(ANX) and stress (STR) (Lovibond S.H. & Lovibond P.F. 1995). The DASS21 is a set of three 
self-report scales (7 items per scale) designed to measure the negative emotional states of 
depression, anxiety and stress.  
The Depression Scale assesses dysphoria, hopelessness, devaluation of life, self-deprecation, 
lack of interest/involvement, anhedonia, and inertia. The Anxiety Scale assesses autonomic 
arousal, skeletal muscle effects, situational anxiety, and subjective experience of anxious 
affect. The Stress Scale is sensitive to levels of chronic non-specific arousal. It assesses 
difficulty relaxing, nervous arousal, and being easily upset/agitated, irritable/over-reactive 
and impatient. In this questionnaire, the higher the score the higher the level of depression, 
anxiety and/or stress.  
The DASS Anxiety Scale correlates 0.81 with the Beck Anxiety Inventory and the DASS 
depression scale correlates 0.74 with the Beck Depression Inventory in its original form, 
DASS42 ( Lovibond P.F.and Lovibond S.H. 1995 ). 
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4. Results 
In the study period, 161 patients with an ICD commenced the CR program on 178 occasions. 
Mean age ( + SD ) was 61 + 10 years, 85% of patients were male, and mean LVEF was 30 + 
10%. 
Medical history included hyperlipidaemia 85%, hypertension 52%, previous myocardial 
infarction 48%, current smoking 29%, diabetes mellitus 26%, chronic obstructive airways 
disease 17%, previous cerebrovascular accident ( CVA ) 11% and depression 11%. 
Cardioactive medications used were beta-blockers 85%, angiotensin converting enzyme 
inhibitors ( ACEI ) or angiotensin receptor blockers 72%, specific antiarrhythmic drugs 17%, 
nitrates 15% and digoxin 10%. Adherence to medication was emphasized, and regularly 
checked with both patients and carers. 
Functional capacity testing was performed in all patients prior to CR commencement. 
Treadmill exercise tests ( EST ) were performed in 78%, 6 minute walk tests ( 6MWT ) in 21% 
and timed up and go tests in 1%. Mean number of exercise sessions attended during the CR 
program was 9 + 7. Program completion rate was 62%, with the drop-out rate for non-
medical reasons being 14%. For those patients who completed CR, the same functional test 
was repeated at the end of the program.  
There were no deaths or ventricular tachyarrhythmias in study patients while they were 
exercising or undergoing a functional capacity test. There were 4 deaths in the study group 
at 1 year follow-up (mortality 2%). Two of these patients died 6 months post CR program, 
and 2 others died while on the program. These latter 2 patients were admitted to hospital 
with heart failure which proved refractory to treatment.  
Other admissions to hospital while patients were on the CR program were for the following 
reasons – acute heart failure 3%, displaced lead 1%, percutaneous interventions 1%, CVA 
0.5%, ICD activations 0.5% and miscellaneous causes 2%. 
Functional capacity increased significantly in patients completing the CR program. For 
those undertaking EST assessment, MET levels rose from 6.9 + 2.2 pre CR to 9.6 + 2.8 post 
CR, p < 0.001. For the 6MWT group, distance walked increased from 373 + 114 metres pre 
CR to 430 + 126 metres post CR, p = 0.04. 
Resting heart rate at the initial functional assessment was 75 + 14 beats/min, rising to  
109 + 21 beats/min at peak exercise ( p < 0.001 ). Systolic BP rose from a baseline of 111 + 
18 mmHg to a peak of 131 + 25 mmHg ( p < 0.001 ) during the initial functional 
assessment.  
For patients completing the CR program, QOL indicators also improved between pre and 
post CR assessments, with respect to most SF-36 domains, and also the DASS21 Depression 
and Anxiety Scales ( Table 1 ). 
5. Discussion 
The patients in this study had significant left ventricular dysfunction, as well as propensity 
for ventricular tachyarrhythmias, but were clinically well enough to commence a CR 
program and to participate in the exercise component which was a key core feature of CR at 
Westmead Hospital. The majority of participants completed the program, and all patients 
were accounted for at follow-up. Standard antifailure therapy was taken by a clear majority 
of patients, with over 80% being on beta blockers and over 70% on ACEI or angiotensin 
receptor blockers. 
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SF-36 Domains (n=77) Pre Program Post Program p-value ABS 1995 Mean 
(n >18,500) 
General Health 62+20 66+21 0.09 72 
Physical Functioning 54+23 74+21 <0.001 83 
Role-Physical 26+37 55+40 0.049 80 
Bodily Pain 65+24 82+22 <0.001 77 
Vitality 54+22 69+19 <0.001 65 
Social Functioning 64+28 82+21 <0.001 85 
Role-Emotional 48+44 72+40 <0.001 83 
Mental Health 72+20 77+18 0.21 76 
Total 108+17 120+16 <0.001  
DASS21 (n=78)     
Depression 7.4+8.8 5.2+7.6 0.006  
Anxiety 6.9+6.8 5.2+6.1 0.005  
Stress 8.4+7.7 7.2+7.5 0.10  
Table 1. QOL assessments pre and post CR in ICD patients. 
5.1 Safety of exercise 
This study extended previous observations that exercise training as well as formal EST 
assessments are safe, and do not promote ICD activations.  
There have been theoretical concerns that ventricular tachyarrhythmias can be provoked by 
adrenergic stimulation, such as occurs with exercise, but the present study and other studies 
of exercise testing or exercise training in patients with ICDs have now consistently shown 
that this concern is not warranted ( Hussein & Thomas 2008 ). While this may in part be 
related to the high usage of beta blockers in the present study, there is data from both 
animal and clinical studies to suggest that exercise training might potentially reduce the 
incidence of ventricular tachyarrhythmias by shifting autonomic balance towards an 
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increase in vagal tone, and by reducing the frequency of ischaemic episodes which may 
trigger arrhythmias ( see reviews by Hussein & Thomas 2008; Lewin, et al., 2001 ).  
5.2 Effects of exercise on functional capacity 
Exercise prescription and training can also improve general physical fitness, and this in turn 
can decrease the likelihood of an early inappropriately fast sinus tachycardia with exercise, 
which could potentially lead to inappropriate ICD discharges if heart rate cut-offs for ICD 
shocks are exceeded. The heart rate response to exercise noted during the CR program can, 
in turn, help optimize the setting of heart rate cut-offs for ICD activation, so helping to 
reduce inappropriate ICD discharges. 
Functional capacity improved substantially during the course of the 6 week CR program 
in this study, but MET levels achieved were still short of the 11-14 MET workloads 
achieved at the Westmead Hospital CR program in patients without ICDs ( Kovoor, et al., 
2006 ). The improvement in MET levels achieved in the Westmead ICD patients was 2-3 
METS on average, which could potentially translate to a substantial reduction in mortality 
( up to 13% reduction for each increase in workload of 1 MET – Kokkinos et al., 2007 ), 
particularly if the improved functional capacity can be maintained after completion of the 
CR program. 
Exercise training in patients with heart failure have demonstrated that most of the benefit 
appears to be the result of peripheral adaptations, although some improvements in cardiac 
function have also been documented ( Briffa et al., 2009; Haykowsky et al., 2007 ). The 
present study did not re-evaluate LVEF at 1 yr post CR, and it is not known whether the low 
1 year mortality observed was due to improvement in left ventricular function. 
Demonstration to patients that they can safely exercise to relatively high workloads without 
setting off the ICD is an important way of building patient confidence and self esteem, as 
well as ensuring that they have improved endurance, reduced fatigue and increased 
muscular strength ( Lampman & Knight 2000 ). This reinforces the desirability of continuing 
a regular exercise program after the CR program has been completed. 
5.3 Effects on quality of life measures 
Psychosocial problems of patients with ICDs include anxiety, depression, insomnia, fear of 
either shocks from the device or device malfunction, and reduced quality of life in general 
(Hussein & Thomas 2008; Sears et al., 2005; Sola & Bostwick 2005). As shown in Table 1, 
QOL in ICD patients in this study was poor when compared with the general Australian 
population, but did improve significantly over the course of the 6 week CR program. This 
study showed significant improvements in QOL indicators as assessed by both the SF-36 
domains and DASS21 scales.  
The improvements in QOL documented in the present study were in the SF-36 domains of 
physical functioning, social functioning, physical and emotional roles, bodily pain and 
vitality. Anxiety and Depression DASS Scales also showed favourable outcomes during the 
course of the CR program. These major benefits probably derive from a combination of 
factors, including exercise training, and active educational and counselling sessions giving 
guidance on general health matters, secondary prevention, lifestyle change and psychosocial 
support. There may be a differential benefit for older and younger age groups ( Crossmann 
et al., 2010 ) but this was not examined in the present study. 
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ICD patients are a heterogeneous group, both from the physical and psychological points of 
view. CR programs should have certain core components including exercise, education and 
psychological interventions. The individual needs of patients will have to be addressed by 
having sufficient flexibility of CR programs so as to tailor the individual programs to the 
needs of the patients. 
6. Conclusion 
This study shows that exercise testing and exercise training is safe in ICD patients who are 
clinically stable, and that exercise does not provoke ventricular tachyarrhythmias. The ICD 
patients also gain significant improvements in functional capacity and QOL outcomes.  
Future studies will need to evaluate whether these benefits are maintained over time. 
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